文摘
On March 21, 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the ass="boldFont">iass="boldFont">2 = ass="boldFont">initiating ass="boldFont">innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; an id="intref0010" class="interref" data-locatorType="url" data-locatorKey="http://www.TearFilm.org">www.TearFilm.orga>an>) and supported by Dompé. The TFOS ass="boldFont">iass="boldFont">2 meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS ass="boldFont">iass="boldFont">2 meeting.